awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38946563-6F73EB4F-4EEE-458E-9755-C1062EA0E421
Q38946563-6F73EB4F-4EEE-458E-9755-C1062EA0E421
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-6F73EB4F-4EEE-458E-9755-C1062EA0E421
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.
P1476
Q38946563-6F73EB4F-4EEE-458E-9755-C1062EA0E421
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-6F73EB4F-4EEE-458E-9755-C1062EA0E421
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
23f52f97b67626134dade91f9fcf61161a05e2b6
P1476
Evaluation of the immunogenici
......
izumab during Phase I studies.
@en